Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for Chronic Obstructive Pulmonary Disease (COPD)
Key Data:
Drug (brand/generic)
Ariflo (cilomilast)
Company/licensee
GlaxoSmithKline Pharmaceuticals
Therapy class
PDE-IV inhibitor
Product description
Oral selective phosphodiesterase (PDE) IV inhibitor
Product description
Oral selective phosphodiesterase (PDE) IV inhibitor
Current indication
Treatment of COPD
Market sector
Respiratory
Development status
Pre-registration
